HSPA5 and lung carcinoma: A recent lung cancer study by Wang et al. [148], though finding no correlation of increased expression of BiP with pathologic tumor type, did relate augmented expression in less differentiated tumors and in more advanced stage III tumors, both aspects predicting a poorer prognosis.